Emergent Transcatheter Tricuspid Edge-to-Edge Repair for Right Ventricular Shock From Tricuspid Regurgitation in Hypertrophic Cardiomyopathy.

Nicholas J Valle, Amin Yehya, Animesh Rathore, Erich L Kiehl, Matthew R Summers

Abstract readCase Reports

In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicholas J ValleEastern Virginia Medical School, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Internal Medicine Residency Program, Norfolk, Virginia, USA. Electronic address: vallenj@odu.edu.

Amin YehyaSentara Medical Group, Sentara Health, Department of Advanced Heart Failure, Mechanical Circulatory Support, and Transplant Cardiology, Virginia Beach, Virginia, USA; Eastern Virginia Medical School, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Department of Cardiology, Norfolk, Virginia, USA.

Animesh RathoreSentara Medical Group, Sentara Health, Department of Vascular Surgery, Virginia Beach, Virginia, USA.

Erich L KiehlEastern Virginia Medical School, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Department of Cardiology, Norfolk, Virginia, USA; Sentara Medical Group, Sentara Health, Department of Electrophysiology, Virginia Beach, Virginia, USA.

Matthew R SummersEastern Virginia Medical School, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Department of Cardiology, Norfolk, Virginia, USA; Sentara Medical Group, Sentara Health, Department of Structural Cardiology and Complex Coronary Intervention, Virginia Beach, Virginia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTranscatheter tricuspid edge-to-edge repair (T-TEER) is an emerging technology used to treat severe tricuspid regurgitation (TR). The pivotal trials demonstrating the safety and efficacy of T-TEER exclude patients with severely reduced left ventricular function (≤20%). CASE SUMMARY: We demonstrate the use of T-TEER in a patient with end-stage hypertrophic cardiomyopathy who suffered acute, torrential TR and subsequently developed cardiogenic shock as a complication of high-risk transvenous lead extraction. WHY BEYOND THE GUIDELINES: Currently, there are no guidelines addressing the nonsurgical emergent management of acute TR. DISCUSSION: The TriClip system (Abbott) may have certain advantages when used in managing acute primary TR compared with other valve repair and/or replacement approaches. TAKE-HOME MESSAGE: TriClip can be considered for urgent use to correct severe TR in hemodynamically unstable patients who are not surgical candidates.

Indexed as

3-dimensional imagingcardiomypathychronic heart failurecomplicationhemodynamicsreduced ejection fractiontricuspid valvevalve repair

Identifiers

PMID40681231

DOI10.1016/j.jaccas.2025.104448

PMCPMC12441390

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.